Luteolin

Overview

Luteolin (3',4',5,7-tetrahydroxyflavone) is a common dietary flavone found in celery, parsley, green pepper, chamomile tea, artichoke, and perilla leaves. Among the thousands of polyphenolic compounds identified in the human diet, luteolin has emerged as one of the most potent natural inhibitors of neuroinflammation — the chronic microglial activation and inflammatory cytokine production increasingly recognized as a driver of cognitive decline, brain fog, autism spectrum-associated neuroinflammation, and neurodegenerative diseases. Luteolin inhibits the activation of microglia (the brain's resident immune cells) by suppressing NF-kB, AP-1, and STAT3 signaling pathways, reducing production of TNF-alpha, IL-1beta, IL-6, and nitric oxide. It also stabilizes mast cells, preventing the release of histamine, tryptase, and inflammatory mediators that can disrupt the blood-brain barrier and trigger neuroinflammatory cascades.

The mast cell-stabilizing and anti-neuroinflammatory properties of luteolin have attracted particular clinical interest in conditions characterized by brain fog and cognitive impairment. Dr. Theoharides at Tufts University has published extensive research on luteolin's ability to inhibit mast cell degranulation and reduce brain inflammation, leading to the development of a liposomal luteolin formulation for improved bioavailability. In clinical studies and case series, luteolin supplementation has shown benefits in autism spectrum disorder (reducing irritability, hyperactivity, and lethargy), post-COVID cognitive impairment ("long COVID brain fog"), mast cell activation syndrome (MCAS), and chemotherapy-induced cognitive dysfunction ("chemo brain"). The compound's anti-allergic effects extend to peripheral mast cell conditions, where it reduces histamine release, prostaglandin D2 production, and inflammatory cytokine secretion.

Beyond neuroinflammation, luteolin demonstrates broad anticancer activity through multiple mechanisms: inhibition of topoisomerase I and II, induction of apoptosis via p53 and caspase pathways, suppression of angiogenesis through VEGF inhibition, and modulation of drug resistance through P-glycoprotein inhibition. It also exhibits cardioprotective effects (through eNOS upregulation and LDL oxidation inhibition), hepatoprotective activity, and antidiabetic properties via alpha-glucosidase inhibition. Luteolin pairs effectively with quercetin for broad flavonoid coverage and complementary mast cell stabilization, palmitoylethanolamide (PEA) for combined neuroinflammatory and mast cell support, curcumin for synergistic NF-kB inhibition, and vitamin-c which enhances flavonoid bioactivity. Bioavailability is a key consideration — liposomal or nano-formulated luteolin preparations significantly improve absorption compared to free luteolin, with typical supplemental doses ranging from 100–400 mg/day.

Mechanism of Action

Luteolin (3',4',5,7-tetrahydroxyflavone) is a naturally occurring flavone found in celery, parsley, green peppers, and chamomile that exerts broad anti-inflammatory effects through simultaneous inhibition of multiple signaling nodes. Its primary anti-inflammatory mechanism involves direct inhibition of IκB kinase (IKK), preventing phosphorylation and degradation of IκBα, thereby trapping NF-κB in the cytoplasm and blocking transcription of pro-inflammatory genes including TNF-alpha, IL-1beta, IL-6, COX-2, and iNOS. Luteolin also directly inhibits the JAK2/STAT3 signaling axis by binding to the ATP-binding pocket of JAK2, suppressing STAT3 phosphorylation and nuclear translocation, which reduces expression of anti-apoptotic proteins (Bcl-2, survivin) and cell cycle regulators (cyclin D1).

Luteolin is one of the most potent natural mast cell stabilizers, inhibiting mast cell degranulation and histamine release by blocking calcium influx through store-operated calcium channels and inhibiting phospholipase C-gamma (PLCγ) activation. It suppresses TLR4/MyD88-dependent signaling in microglia and macrophages, reducing production of neurotoxic mediators including nitric oxide, prostaglandin E2, and matrix metalloproteinase-9. As a phosphodiesterase 4 (PDE4) inhibitor, luteolin increases intracellular cAMP levels, which activates protein kinase A (PKA) and CREB signaling, promoting anti-inflammatory and neuroprotective gene expression.

In the nervous system, luteolin crosses the blood-brain barrier and directly suppresses microglial activation, reducing neuroinflammation implicated in Alzheimer's disease, multiple sclerosis, and autism spectrum disorders. It activates the Nrf2/ARE pathway, upregulating antioxidant enzymes and promoting neuronal survival. Recent research has identified luteolin as a natural CD38 inhibitor, which preserves intracellular NAD+ levels by blocking the ectoenzyme that degrades NAD+ on cell surfaces—linking luteolin to anti-aging mechanisms through enhanced sirtuin activity. Luteolin also inhibits xanthine oxidase, reduces uric acid production, and modulates estrogenic activity through selective binding to estrogen receptor beta (ERβ), contributing to its neuroprotective and anti-cancer properties.

Reconstitution Calculator

Research

Safety Profile

Luteolin supplements have limited human safety data and may cause gastrointestinal issues or interact with blood thinners and blood pressure medications. Due to potential hormonal effects, individuals with hormone-sensitive cancers should avoid it, and it is not recommended during pregnancy. Consult a healthcare professional before use.

Pharmacokinetic Profile